317 related articles for article (PubMed ID: 26291283)
1. Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.
Huang D
Neurology; 2015 Sep; 85(11):1001-3. PubMed ID: 26291283
[No Abstract] [Full Text] [Related]
2. Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod.
Achtnichts L; Obreja O; Conen A; Fux CA; Nedeltchev K
JAMA Neurol; 2015 Oct; 72(10):1203-5. PubMed ID: 26457631
[No Abstract] [Full Text] [Related]
3. Disseminated Cryptococcosis in a 63-year-old Patient with Multiple Sclerosis Treated with Fingolimod.
Seto H; Nishimura M; Minamiji K; Miyoshi S; Mori H; Kanazawa K; Yasuda H
Intern Med; 2016; 55(22):3383-3386. PubMed ID: 27853088
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: Here come the opportunistic infections?
Carpenter AF; Goodwin SJ; Bornstein PF; Larson AJ; Markus CK
Mult Scler; 2017 Feb; 23(2):297-299. PubMed ID: 28165320
[TBL] [Abstract][Full Text] [Related]
5. Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod.
Forrestel AK; Modi BG; Longworth S; Wilck MB; Micheletti RG
JAMA Neurol; 2016 Mar; 73(3):355-6. PubMed ID: 26751160
[No Abstract] [Full Text] [Related]
6. [Treatment for multiple sclerosis in patients with collagen diseases].
Kohriyama T; Ochi K
Nihon Rinsho; 2015 Sep; 73 Suppl 7():234-40. PubMed ID: 26480706
[No Abstract] [Full Text] [Related]
7. Severe disease exacerbations in patients with multiple sclerosis after discontinuing fingolimod.
Członkowska A; Smoliński Ł; Litwin T
Neurol Neurochir Pol; 2017; 51(2):156-162. PubMed ID: 28209440
[TBL] [Abstract][Full Text] [Related]
8. Five cases of malignant melanoma during fingolimod treatment in Dutch patients with MS.
Killestein J; Leurs CE; Hoogervorst ELJ; van Eijk J; Mostert JP; van den Eertwegh AJM; Uitdehaag BMJ
Neurology; 2017 Aug; 89(9):970-972. PubMed ID: 28768850
[No Abstract] [Full Text] [Related]
9. Herpes zoster: a potential risk associated with fingolimod treatment.
Mayor Ibarguren A; Gómez Fernández C; Tallón Barranco A; Fernández Fournier M; González Ramos J; Romero Gómez MP; Herranz Pinto P
Int J Dermatol; 2015 Sep; 54(9):e373-5. PubMed ID: 26173466
[No Abstract] [Full Text] [Related]
10. [Fingolimod].
Hashi Y; Kondo T
Nihon Rinsho; 2015 Sep; 73 Suppl 7():205-11. PubMed ID: 26480701
[No Abstract] [Full Text] [Related]
11. Combining secukinumab and fingolimod to successfully treat ankylosing spondylitis and multiple sclerosis - A novel approach.
Nisar MK
Biologicals; 2019 Jul; 60():93-94. PubMed ID: 31204079
[No Abstract] [Full Text] [Related]
12. Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger Than Age 18 Years.
Fragoso YD; Alves-Leon SV; Barreira AA; Callegaro D; Brito Ferreira ML; Finkelsztejn A; Gomes S; Magno Goncalves MV; Moraes Machado MI; Marques VD; Cunha Matta AP; Papais-Alvarenga RM; Apostolos Pereira SL; Tauil CB
Pediatr Neurol; 2015 Aug; 53(2):166-8. PubMed ID: 26026897
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.
Yamout BI; Zeineddine MM; Tamim H; Khoury SJ
J Neuroimmunol; 2015 Dec; 289():93-7. PubMed ID: 26616877
[TBL] [Abstract][Full Text] [Related]
14. Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis.
Gündüz T; Kürtüncü M; Eraksoy M
Mult Scler Relat Disord; 2017 Jan; 11():1-3. PubMed ID: 28104247
[No Abstract] [Full Text] [Related]
15. Fingolimod suppresses bone resorption in female patients with multiple sclerosis.
Miyazaki Y; Niino M; Kanazawa I; Suzuki M; Mizuno M; Hisahara S; Fukazawa T; Takahashi E; Amino I; Ochi R; Nakamura M; Akimoto S; Minami N; Fujiki N; Doi S; Shimohama S; Terayama Y; Kikuchi S
J Neuroimmunol; 2016 Sep; 298():24-31. PubMed ID: 27609272
[TBL] [Abstract][Full Text] [Related]
16. Hepatic involvement culminating in cirrhosis in a child with disseminated cryptococcosis.
Goenka MK; Mehta S; Yachha SK; Nagi B; Chakraborty A; Malik AK
J Clin Gastroenterol; 1995 Jan; 20(1):57-60. PubMed ID: 7884181
[TBL] [Abstract][Full Text] [Related]
17. Early relapse with tumefactive MS lesion upon initiation of fingolimod therapy.
Boangher S; Goffette S; Van Pesch V; Mespouille P
Acta Neurol Belg; 2016 Mar; 116(1):95-7. PubMed ID: 26071761
[No Abstract] [Full Text] [Related]
18. Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
Matoula T; Nikolaou V; Marinos L; Katsavos S; Nasis G; Economidi A; Karampidou K; Stratigos A; Antoniou C
Mult Scler; 2016 Oct; 22(12):1630-1631. PubMed ID: 27053634
[No Abstract] [Full Text] [Related]
19. Glioblastoma in a fingolimod-treated multiple sclerosis patient: Causal or coincidental association?
London F; Cambron B; Jacobs S; Delrée P; Gustin T
Mult Scler Relat Disord; 2020 Jun; 41():102012. PubMed ID: 32088655
[No Abstract] [Full Text] [Related]
20. JAAD grand rounds quiz*: Renal transplant patient with vegetative plaque on the cheek.
Liggett J; Ozog D
J Am Acad Dermatol; 2010 Jul; 63(1):177-9. PubMed ID: 20542189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
